A Study to Learn About Brigatinib Treatment Information Available in Chinese Participants With Non-Small-cell Lung Cancer (NSCLC)
Clinical trial NCT05721950 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05721950
- Sponsor
- Takeda
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-01-17
- Primary completion
- 2028-03-20
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.